Humankind Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,804
Closed -$583K 70
2025
Q3
$583K Buy
1,804
+455
+34% +$142K 0.13% 79
2025
Q2
$525K Sell
1,349
-435
-24% -$175K 0.13% 86
2025
Q1
$776K Buy
1,784
+89
+5% +$35.7K 0.2% 67
2024
Q4
$625K Buy
1,695
+505
+42% +$211K 0.16% 70
2024
Q3
$619K Buy
1,190
+66
+6% +$35.3K 0.22% 67
2024
Q2
$609K Sell
1,124
-190
-14% -$100K 0.16% 70
2024
Q1
$681K Sell
1,314
-20
-1% -$9.95K 0.18% 64
2023
Q4
$629K Sell
1,334
-10
-0.7% -$4.62K 0.19% 62
2023
Q3
$585K Sell
1,344
-31
-2% -$14.1K 0.24% 55
2023
Q2
$611K Buy
1,375
+496
+56% +$229K 0.24% 56
2023
Q1
$404K Buy
879
+4
+0.5% +$1.9K 0.17% 75
2022
Q4
$449K Buy
875
+18
+2% +$9.14K 0.19% 71
2022
Q3
$389K Buy
857
+126
+17% +$60.3K 0.19% 69
2022
Q2
$353K Buy
731
+122
+20% +$60.4K 0.17% 72
2022
Q1
$299K Sell
609
-23
-4% -$10.5K 0.12% 89
2021
Q4
$293K Buy
632
+6
+1% +$2.52K 0.12% 91
2021
Q3
$233K Buy
626
+21
+3% +$7.98K 0.11% 98
2021
Q2
$231K Buy
+605
New +$231K 0.11% 87

Other funds holding ELV

Humankind Investments's ELV Position: Q4 2025 in Review

Humankind Investments sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 1,804 shares — an estimated $583K sold.

Humankind Investments first reported a position in ELV in Q2 2021 and held it in 18 quarters. The position peaked at $776K in Q1 2025. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Humankind Investments reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Humankind Investments sold 1,804 Elevance Health shares in Q4 2025, an estimated $583K.
  • Humankind Investments first reported a position in Elevance Health in Q2 2021 and held it in 18 quarters.
  • Humankind Investments's Elevance Health position peaked at $776K in Q1 2025.
  • 1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.